Skip to main content
. 2015 Sep 24;10:2017–2025. doi: 10.2147/COPD.S91654

Table 1.

Clinical characteristics and sample collection data of the four study groups

Control Asthma COPD ACOS
Number of patients (n) 21 44 21 20
Female/male 12/9 36/8 10/11 12/8
Age (years) 38.00±3.34 44.84±2.38 66.33±2.63 65.45±1.86
BMI (kg/m2) 26.80±1.31 24.33±0.95 29.12±1.45
Smoking habits, n (%)
 Current smoker 0 (0) 1 (2.25) 4 (19) 5 (25)
 Ex-smoker 1 (4.75) 2 (4.5) 15 (71.25) 14 (70)
 Never-smoker 20 (95) 41 (93.25) 2 (9.5) 1 (5)
GOLD category, n (%) II–IV I–IV
 A 0 (0) 3 (15)
 B 2 (9.5) 9 (45)
 C 0 (0) 0 (0)
 D 19 (90.5) 8 (40)
Allergic rhinitis or atopic nature, n (%) 0 (0) 34 (77) 0 (0) 10 (50)
Number of comorbidities, mean [range] 0 [0] 0.34 [0–4]a 2.19 [0–4] 0.70 [0–2]
Sample collected in summer season, n (%) 2 (9.5) 3 (6.75) 5 (24) 0 (0)

Notes: Data expressed as mean ± SEM if not stated otherwise.

a

Only one asthmatic patient had four comorbidities.

Abbreviations: ACOS, asthma–COPD overlap syndrome; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; SEM, standard error of mean.